Information about the 2019 Novel Coronavirus
Fexofenadine Use in Gastroesophageal Reflux Symptoms
Trial ID or NCT#
The investigators wish to study the effectiveness of Fexofenadine (an over the counter allergy pill) for the treatment of gastroesophageal reflux symptoms in patients who still have symptoms despite being on a proton pump inhibitor. The investigators will do this by giving participants both Fexofenadine (an H1 blocker) for 2 weeks and placebo (sugar pill) for 2 weeks. The participants will not know which drug they are getting at a particular time. This will help the investigators better assess the true effectiveness of Fexofenadine.
A Randomized, Double Blind, Crossover Trial Comparing Fexofenadine to Placebo for the Treatment of Proton Pump Inhibitor Refractory Gastroesophageal Reflux Symptoms
Contact us to find out if this trial is right for you.
George Triadafilopoulos, MD
About this Clinical Trial
Your Message Will Go ToGeorge Triadafilopoulos, MD
To:George Triadafilopoulos, MD
Go Back To The Trial